Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.51 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.51 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | SCD | O00767 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12517362 | 0.91 | CYP19A1 (0.59) | CYP19A1CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL384212 | 0.86 | MAOB (0.56) | ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL12516200 | 0.85 | CYP19A1 (0.54) | LMNACYP19A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL11529553 | 0.85 | GAA (0.60) | ALDH1A1LMNACYP19A1CHRNB2CHRNB4 | |
| SCHEMBL16701110 | 0.85 | SRD5A2 (0.57) | CYP19A1SCDSRD5A2GSTP1CA12 | |
| SCHEMBL25960519 | 0.84 | CYP19A1 (0.57) | ALDH1A1CYP19A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL14901649 | 0.84 | TP53 (0.54) | ALDH1A1CYP19A1MAOBKMT2AMEN1 | |
| SCHEMBL16364112 | 0.83 | CYP19A1 (0.53) | ALDH1A1LMNACYP19A1CHRNB2CHRNB4 | |
| SCHEMBL29644530 | 0.83 | CYP19A1 (0.56) | ALDH1A1LMNACYP19A1CHRNB2CHRNB4 | |
| SCHEMBL26673955 | 0.83 | CYP19A1 (0.56) | CYP19A1CHRNB2CHRNB4CHRNA3CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3692101-B1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTR S R L (IT) | 2022-01-12 | — | — | EP | claimed |
| EP-3692101-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | Alfa Instruments S.r.l. (IT) | 2020-08-12 | — | — | EP | claimed |
| WO-2019068935-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTRUMENTS S.R.L. (IT) | 2019-04-11 | — | — | WO | claimed |
| US-20250146186-A1 | A METHOD OF PREPARING MULTI-FUNCTIONALIZED CELLULOSE AND USE THEREOF FOR PREPARING MULTI-FUNCTIONALIZED NANOFIBRILLATED CELLULOSE | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2025-05-08 | — | — | US | disclosed |
| EP-4479437-A1 | A METHOD OF PREPARING MULTI-FUNCTIONALIZED CELLULOSE AND USE THEREOF FOR PREPARING MULTI-FUNCTIONALIZED NANOFIBRILLATED CELLULOSE | Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR) | 2024-12-25 | — | — | EP | disclosed |
| CN-119110812-A | Method for producing multifunctional cellulose and use thereof for producing multifunctional nanofibrillated cellulose | 法国国家农业、食品和环境研究所 | 2024-12-10 | — | — | CN | disclosed |
| WO-2023156348-A1 | A METHOD OF PREPARING MULTI-FUNCTIONALIZED CELLULOSE AND USE THEREOF FOR PREPARING MULTI-FUNCTIONALIZED NANOFIBRILLATED CELLULOSE | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2023-08-24 | — | — | WO | disclosed |
| EP-4227323-A1 | A METHOD OF PREPARING MULTI-FUNCTIONALIZED CELLULOSE AND USE THEREOF FOR PREPARING MULTI-FUNCTIONNALIZED NANOFIBRILLATED CELLULOSE | Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (FR) | 2023-08-16 | — | — | EP | disclosed |
| EP-3692101-B1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTR S R L (IT) | 2022-01-12 | — | — | EP | disclosed |
| EP-3692101-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | Alfa Instruments S.r.l. (IT) | 2020-08-12 | — | — | EP | disclosed |
| WO-2019068935-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTRUMENTS S.R.L. (IT) | 2019-04-11 | — | — | WO | disclosed |
| WO-2018049534-A1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC. (CA) | 2018-03-22 | — | — | WO | disclosed |
| US-20130109758-A1 | BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109758-A1 | BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | SHBG, KLK3, HSD17B11 | ALDH1A1 179/4885LMNA 1050/4885CYP19A1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.